Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 16, Issue 8, 2002, Pages 860-862

  Permanne, Bruno ^a   Adessi, Céline ^a   Saborio, Gabriela P ^a   Fraga, Santiago ^a   Frossard, Marie José ^a   Van Dorpe, J ^a   Dewachter, Ilse ^a   Banks, William A ^a   Van Leuven, Fred ^a   Soto, Claudio ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CELL DEATH; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOUSE; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE; VASCULARIZATION;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL DEATH; DISEASE MODELS, ANIMAL; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEURONS; PEPTIDE FRAGMENTS; PRESENILIN-1;

MLCS; MLOWN;

EID: 0036615884     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.01-0841fje     Document Type: Article

References (0)